GH Research PLC is a clinical-stage biopharmaceutical company developing treatment for psychiatric and neurological disorders. The company focuses on therapies for treatment-resistant depression. GH Research PLC was incorporated in 2018 and is based in Dublin, Ireland.
Name / Ticker | Price | Zen Rating |
---|---|---|
$3.07 | A | |
$8.24 | A | |
$24.29 | A |